Ezra Klein

Because like there's going to be money for it.

There's going to be attention for it.

And so, yeah, I mean, a lot of people in this country are very, very sick and what they need is treatment for chronic illness.

But I think there's gonna be a real push in the system towards treating these people who what they are is not very sick.

What they are is well and they want to be weller.

I mean, this goes to something that you wrote about in a piece you did for The Times, which is that these are the first blockbuster drugs to collide with our wellness-obsessed algorithmic age.

And yeah, I mean, I must have clicked at some point on Reddit who tried content on X, and now every time I turn on...

The system, the platform, I get these videos from people like, tell me how great retitutride is.

And there's a huge boom in people just ordering peptides from places where they can't really tell what's in them.

The New Yorker tested some of these and found a lot of them have...

lead or impurities or things you don't want or they're not at the right dose.

There's something wrong.

We got these blockbuster drugs and you might expect everybody to be really excited and be on them.

But it seems to have exploded into this biohacking moment in which it's like if something like Magovi could exist, well, then who knows what is out there?

And you should order it from China and inject it into yourself and find out.

Like, what do you make of it?

I guess this does reflect what I've told my algorithm to tell me, although not intentionally.

I see so many people just posting about random studies that are not full randomized controlled trials, are often not even in human beings, and being like, see, look at this amazing mechanism and look at these early results.

And at least according to them, they're getting them compounded and ordering them.

I am fascinated by this because there is some weird overlap between the community of people who are incredibly skeptical of vaccines, of the FDA.